Details for New Drug Application (NDA): 021055
✉ Email this page to a colleague
The generic ingredient in TARGRETIN is bexarotene. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the bexarotene profile page.
Summary for 021055
Tradename: | TARGRETIN |
Applicant: | Valeant Luxembourg |
Ingredient: | bexarotene |
Patents: | 0 |
Suppliers and Packaging for NDA: 021055
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TARGRETIN | bexarotene | CAPSULE;ORAL | 021055 | NDA | Bausch Health US, LLC | 0187-5526 | 0187-5526-75 | 1 BOTTLE in 1 CARTON (0187-5526-75) / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE |
TARGRETIN | bexarotene | CAPSULE;ORAL | 021055 | NDA AUTHORIZED GENERIC | Oceanside Pharmaceuticals | 68682-003 | 68682-003-10 | 1 BOTTLE in 1 CARTON (68682-003-10) / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
Approval Date: | Dec 29, 1999 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021055
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Luxembourg | TARGRETIN | bexarotene | CAPSULE;ORAL | 021055-001 | Dec 29, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription